share_log

恩华药业(002262.SZ):新药奥赛利定注射液(TRV130)去年实现销售1800万元左右

Enhua Pharmaceutical (002262.SZ): The new drug Oselidine Injection (TRV130) achieved sales of around 18 million yuan last year

Gelonghui Finance ·  Apr 9 05:28

Gelonghui, April 9丨Enhua Pharmaceutical (002262.SZ) held a performance briefing on April 8, 2024 to discuss “How much was the new drug R130 sold last year, and how much was the gross profit?” The company replied that the new drug oselidine injection (TRV130) launched by the company achieved sales of around 18 million yuan last year, and the gross margin was slightly higher than the company's anesthetic products.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment